HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Donadieu Selected Research

Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)

9/2004Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Donadieu Research Topics

Disease

3Autosomal Recessive 3 Severe Congenital Neutropenia
08/2014 - 09/2004
3Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
11/2005 - 06/2003
2Neoplasms (Cancer)
07/2019 - 11/2012
2Hodgkin Disease (Hodgkin's Disease)
10/2016 - 04/2000
2Cerebellar Diseases (Cerebellar Syndrome)
01/2009 - 03/2000
2Neutropenia
11/2005 - 09/2003
1Atopic Dermatitis (Atopic Eczema)
10/2021
1Congenital Bone Marrow Failure Syndromes
09/2015
1Pancytopenia
08/2013
1Splenomegaly
08/2013
1Sarcoidosis (Schaumann Disease)
08/2013
1Dystonia (Limb Dystonia)
07/2009
1Large Granular Lymphocytic Leukemia
01/2008
1Shwachman-Diamond Syndrome
11/2005
1Hypothyroidism
05/2005
1Leukemia
01/2005
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2005
1Bone Marrow Failure Disorders
01/2005
1Infections
09/2003
1Sepsis (Septicemia)
06/2003
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2001
1Residual Neoplasm
10/2001
1Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome)
06/2001
1Hypersensitivity (Allergy)
01/2001
1Sclerosis
04/2000
1Renal Cell Carcinoma (Grawitz Tumor)
03/2000
1Glycogen Storage Disease IB
03/2000

Drug/Important Bio-Agent (IBA)

3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2005 - 03/2000
2SteroidsIBA
08/2013 - 07/2009
2Vinblastine (Vinblastine Sulfate)FDA Link
07/2009 - 04/2000
2Biological ProductsIBA
01/2008 - 04/2000
1dupilumabIBA
10/2021
1Cell-Free Nucleic AcidsIBA
07/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2012
1DeferiproneIBA
01/2009
1AntigensIBA
01/2008
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2005
1CladribineFDA LinkGeneric
11/2005
1Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA
09/2004
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2004
1Anti-Bacterial Agents (Antibiotics)IBA
09/2003
1SulfamethoxazoleFDA LinkGeneric
09/2003
1DNA (Deoxyribonucleic Acid)IBA
06/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2001
1Prednisone (Sone)FDA LinkGeneric
04/2000
1Vincristine (Oncovin)FDA LinkGeneric
04/2000
1Dacarbazine (DIC)FDA LinkGeneric
04/2000
1Hemoglobins (Hemoglobin)IBA
04/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2000
1Mechlorethamine (Nitrogen Mustard)FDA Link
04/2000
1Etoposide (VP 16)FDA LinkGeneric
04/2000
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2000
1Procarbazine (Matulane)FDA Link
04/2000

Therapy/Procedure

6Therapeutics
10/2016 - 03/2000
4Hematopoietic Stem Cell Transplantation
09/2015 - 06/2003
3Drug Therapy (Chemotherapy)
07/2009 - 04/2000
1Transplantation
09/2015
1Stem Cell Transplantation
08/2014
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2005
1Splenectomy
06/2003
1Radiotherapy
04/2000
1Aftercare (After-Treatment)
03/2000